Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy

Table 2 Logistic regression model in 427 patients with HIV/HBVco-infection according to anti-HBV treatment status

	Never treated vs treated patients adjusted OR
Characteristics	(95% CI)	P
N. enrolled per center^§
≥20 patients	1.41 (0.73-2.71)	0.31
Female gender	0.83 (0.39-1.77)	0.64
Immigrant status
Foreign birth	0.74 (0.3-1.8)	0.51
Age at diagnosis
10 years increase	0.78 (0.55-1.11)	0.17
Years since diagnosis*		<0.001
2-10	0.17 (0.08-0.36)
<10	0.08 (0.03-0.25)
Alcohol consumption
Ever	1.51 (0.63-3.62)	0.35
Disease stage°
cirrhosis/HCC	0.39 (0.09-1.78)	0.22
HBeAg
positivity	0.57 (0.28-1.14)	0.11
HCV co-infection
yes	0.91 (0.41-2.02)	0.82
HDV co-infection
yes	0.48 (0.14-1.66)	0.25

Reference: ^§ = ≤20 patients enrolled; * = <2 years;° = chronic hepatitis. OR, odds ratio; CI, confidence interval; HCC, hepatocellular carcinoma.

ISSN: 1756-0500